Results 131 to 140 of about 297,519 (217)

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity. [PDF]

Front Immunol, 2020
Izmirly AM, Alturki SO, Alturki SO, Connors J, Haddad EK.   +4 more
europepmc   +1 more source

The dengue vaccine dilemma [PDF]

The Lancet Infectious Diseases, 2018
openaire   +2 more sources

Impaired Fibrinolysis in the Pathogenesis of Dengue Hemorrhagic Fever [PDF]

, 2002
The mechanisms contributing to bleeding complications in dengue hemorrhagic fever were studied by investigating the pattern of activation of the coagulation and fibrinolytic systems in 50 children with severe dengue hemorrhagic fever.
ten Cate, H, Brandjes, DPM, Hack, C. Erik, Mairuhu, ATA, van der Meer, Jos W. M., Dolmans, Wil M. V., Suharti, Catharina, van Gorp, Eric C. M., Setiati, Tatty E.   +8 more
core  

Dengue vaccines

, 2013
Scott B. Halstead, Stephen J. Thomas
openaire   +1 more source

Dengue vaccines: The role of a correlate of protection in evaluating vaccine safety and risk. [PDF]

Vaccine
Wong JM, Acevedo PK, Whitehead S, Durbin A, DeSale H, Jones FK, Medina FA, Rovira-Diaz E, Prutzman K, Leao IC, Wang T, Desilva A, Harris E, Katzelnick L, Salje H, Weiskopf D, Adams LE, Paz-Bailey G.   +17 more
europepmc   +1 more source

Update on efficacy, safety, and immunogenicity of Dengue vaccines: a systematic review and meta-analysis. [PDF]

Infez Med
Zaçe D, Çekrezi A, Leone M, Ciarpaglini S, Montagnari G, Giacalone ML, Diforti S, Rodriguez-Morales AJ, Iannetta M, Sarmati L.   +9 more
europepmc   +1 more source

Challenges and Opportunities in the Development of Dengue Vaccines: A Comprehensive Review. [PDF]

Adv Biomed Res
Moghadasi R, Yadollahi Fars Y, Nasri H, Momenzadeh M.   +3 more
europepmc   +1 more source

VFC resolution update : Dengue vaccines [PDF]

04-dengue-Santoli-508 ...

core  

From promise to pitfalls: immunological lessons from dengue vaccines and their implications. [PDF]

NPJ Vaccines
Estofolete CF, Saivish MV, Nogueira ML, Vasilakis N.   +3 more
europepmc   +1 more source

TAK-003 (Tetravalent Dengue Vaccine Candidate) [PDF]

Dengue-02-Biswal-508 ...

core